Medtronic plc (MDT)

USD 80.03

(-1.65%)

Revenue Summary of Medtronic plc

  • Medtronic plc's latest annual revenue in 2024 was 32.36 Billion USD , up 3.64% from previous year.
  • Medtronic plc's latest quarterly revenue in 2024 FY was 32.36 Billion USD , up 3.64% from previous quarter.
  • Medtronic plc reported a annual revenue of 31.22 Billion USD in annual revenue 2023, down -1.45% from previous year.
  • Medtronic plc reported a annual revenue of 31.68 Billion USD in annual revenue 2022, up 5.21% from previous year.
  • Medtronic plc reported a quarterly revenue of 7.7 Billion USD for 2024 Q1, down -9.85% from previous quarter.
  • Medtronic plc reported a quarterly revenue of 7.98 Billion USD for 2024 Q2, up 3.66% from previous quarter.

Annual Revenue Chart of Medtronic plc (2024 - 1989)

Historical Annual Revenue of Medtronic plc (2024 - 1989)

Year Revenue Revenue Growth
2024 32.36 Billion USD 3.64%
2023 31.22 Billion USD -1.45%
2022 31.68 Billion USD 5.21%
2021 30.11 Billion USD 4.16%
2020 28.91 Billion USD -5.38%
2019 30.55 Billion USD 2.02%
2018 29.95 Billion USD 0.82%
2017 29.71 Billion USD 3.04%
2016 28.83 Billion USD 42.31%
2015 20.26 Billion USD 19.15%
2014 17 Billion USD 2.5%
2013 16.59 Billion USD 2.51%
2012 16.18 Billion USD 1.58%
2011 15.93 Billion USD 0.73%
2010 15.81 Billion USD 8.34%
2009 14.59 Billion USD 8.02%
2008 13.51 Billion USD 9.89%
2007 12.29 Billion USD 8.92%
2006 11.29 Billion USD 12.31%
2005 10.05 Billion USD 10.65%
2004 9.08 Billion USD 18.55%
2003 7.66 Billion USD 19.57%
2002 6.41 Billion USD 15.47%
2001 5.55 Billion USD 10.71%
2000 5.01 Billion USD 21.3%
1999 4.13 Billion USD 58.71%
1998 2.6 Billion USD 6.83%
1997 2.43 Billion USD 12.41%
1996 2.16 Billion USD 24.49%
1995 1.74 Billion USD 25.27%
1994 1.39 Billion USD 4.72%
1993 1.32 Billion USD 12.86%
1992 1.17 Billion USD 15.22%
1991 1.02 Billion USD 22.09%
1990 836.6 Million USD 12.79%
1989 741.7 Million USD 13.53%

Peer Revenue Comparison of Medtronic plc

Name Revenue Revenue Difference
Abbott Laboratories 40.1 Billion USD 19.31%
Allurion Technologies Inc. 53.46 Million USD -60430.795%
Artivion, Inc. 354 Million USD -9042.27%
Avanos Medical, Inc. 673.3 Million USD -4706.773%
Butterfly Network, Inc. 65.9 Million USD -49010.774%
Butterfly Network, Inc. 65.9 Million USD -49010.774%
Bio-Rad Laboratories, Inc. 2.67 Billion USD -1111.562%
Boston Scientific Corporation 14.24 Billion USD -127.275%
Perspective Therapeutics, Inc. 7.1 Million USD -455474.324%
CONMED Corporation 1.24 Billion USD -2507.994%
Edwards Lifesciences Corporation 6 Billion USD -438.969%
Paragon 28, Inc. 216.38 Million USD -14856.398%
Glaukos Corporation 314.71 Million USD -10183.721%
Globus Medical, Inc. 1.56 Billion USD -1963.404%
Inspire Medical Systems, Inc. 624.79 Million USD -5079.906%
Integer Holdings Corporation 1.59 Billion USD -1926.965%
Nevro Corp. 425.17 Million USD -7511.942%
Owlet, Inc. 54.01 Million USD -59822.237%
Penumbra, Inc. 1.05 Billion USD -2957.471%
Vicarious Surgical Inc. - USD -Infinity%
Smith & Nephew plc 5.54 Billion USD -483.24%
Sonendo, Inc. 43.86 Million USD -73680.919%
STERIS plc 5.13 Billion USD -529.809%
Stryker Corporation 20.49 Billion USD -57.889%
Vapotherm, Inc. 68.66 Million USD -47030.437%
Zimmer Biomet Holdings, Inc. 7.39 Billion USD -337.694%